Evidence map›Paper›PMID 39958272›Full record

ArticleChonnam medical journal2025

Changes in Candidemia during the COVID-19 Pandemic: Species Distribution, Antifungal Susceptibility, Initial Antifungal Usage, and Mortality Trends in Two Korean Tertiary Care Hospitals.

Ahrang Lee, Minji Kim, Sarah Kim, Hae Seong Jeong, Sung Un Shin, David Cho, Doyoung Han, Uh Jin Kim, Jung Ho Yang, Seong Eun Kim and 3 more

Abstract read
In one paragraph

Article in Chonnam medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ahrang LeeDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Minji KimDepartment of Infectious Diseases, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Sarah KimDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Hae Seong JeongDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Sung Un ShinDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
David ChoDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Doyoung HanDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Uh Jin KimDepartment of Infectious Diseases, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Jung Ho YangDepartment of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea.
Seong Eun KimDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Kyung-Hwa ParkDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Sook-In JungDepartment of Infectious Diseases, Chonnam National University Hospital, Gwangju, Korea.
Seung Ji KangDepartment of Infectious Diseases, Chonnam National University Hwasun Hospital, Hwasun, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate changes in candidemia incidence, species distribution, antifungal susceptibility, initial antifungal use, and mortality trends in Korea before and during the COVID-19 pandemic. A retrospective analysis was conducted on candidemia cases from two tertiary care hospitals in Korea between 2017 and 2022. Data were compared between the pre-pandemic (2017-2019) and pandemic (2020-2022) periods. Statistical methods included incidence rate ratios (IRRs) and multivariate Cox regression to assess 30-day mortality risk factors. A total of 470 candidemia cases were identified, with 48.7% occurring pre-pandemic and 51.3% during the pandemic. While the overall incidence of candidemia remained similar across the two periods (IRR 1.15; p=0.13), the incidence in intensive care units (ICUs) significantly increased during the pandemic (IRR 1.50; p<0.01). The distribution of

Indexed as

Antifungal AgentsAntifungal SusceptibilityCandidemiaCOVID-19

Identifiers

PMID39958272
PMCPMC11821990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.